Coleman P, Delvaux E, Kordower J, Boehringer A, Huseby C
Alzheimers Dement. 2025; 21(2):e14555.
PMID: 39912452
PMC: 11851168.
DOI: 10.1002/alz.14555.
Dhiman S, Manoj N, Liput M, Sangwan A, Diehl J, Balcerak A
Int J Mol Sci. 2024; 25(11).
PMID: 38891836
PMC: 11171963.
DOI: 10.3390/ijms25115647.
Gregorczyk P, Porebska N, Zukowska D, Chorazewska A, Gedaj A, Malinowska A
Cell Commun Signal. 2023; 21(1):177.
PMID: 37480072
PMC: 10362638.
DOI: 10.1186/s12964-023-01203-3.
Coetzee A, Carter E, Rodriguez-Fernandez L, Heward J, Wang Q, Karim S
Oncogene. 2022; 42(7):491-500.
PMID: 36357571
PMC: 9918430.
DOI: 10.1038/s41388-022-02513-5.
Cai B, Liu Y, Chong Y, Mori S, Matsunaga A, Zhang H
Mol Cancer. 2022; 21(1):156.
PMID: 35906694
PMC: 9336057.
DOI: 10.1186/s12943-022-01628-3.
FGF8-FGFR1 signaling regulates human GnRH neuron differentiation in a time- and dose-dependent manner.
Yellapragada V, Eskici N, Wang Y, Madhusudan S, Vaaralahti K, Tuuri T
Dis Model Mech. 2022; 15(8).
PMID: 35833364
PMC: 9403748.
DOI: 10.1242/dmm.049436.
Leafy and weedy seadragon genomes connect genic and repetitive DNA features to the extravagant biology of syngnathid fishes.
Small C, Healey H, Currey M, Beck E, Catchen J, Lin A
Proc Natl Acad Sci U S A. 2022; 119(26):e2119602119.
PMID: 35733255
PMC: 9245644.
DOI: 10.1073/pnas.2119602119.
FGFR1 is a potential therapeutic target in neuroblastoma.
Cimmino F, Montella A, Tirelli M, Avitabile M, Lasorsa V, Visconte F
Cancer Cell Int. 2022; 22(1):174.
PMID: 35488346
PMC: 9052553.
DOI: 10.1186/s12935-022-02587-x.
New developments in the biology of fibroblast growth factors.
Ornitz D, Itoh N
WIREs Mech Dis. 2022; 14(4):e1549.
PMID: 35142107
PMC: 10115509.
DOI: 10.1002/wsbm.1549.
FGFR signaling and endocrine resistance in breast cancer: Challenges for the clinical development of FGFR inhibitors.
Servetto A, Formisano L, Arteaga C
Biochim Biophys Acta Rev Cancer. 2021; 1876(2):188595.
PMID: 34303787
PMC: 10537726.
DOI: 10.1016/j.bbcan.2021.188595.
Vitamin D Receptor Mediates a Myriad of Biological Actions Dependent on Its 1,25-Dihydroxyvitamin D Ligand: Distinct Regulatory Themes Revealed by Induction of Klotho and Fibroblast Growth Factor-23.
Haussler M, Livingston S, Sabir Z, Haussler C, Jurutka P
JBMR Plus. 2021; 5(1):e10432.
PMID: 33553988
PMC: 7839824.
DOI: 10.1002/jbm4.10432.
Global Genome Conformational Programming during Neuronal Development Is Associated with CTCF and Nuclear FGFR1-The Genome Archipelago Model.
Decker B, Liput M, Abdellatif H, Yergeau D, Bae Y, Jornet J
Int J Mol Sci. 2021; 22(1).
PMID: 33396256
PMC: 7795191.
DOI: 10.3390/ijms22010347.
Immune Factor, TNFα, Disrupts Human Brain Organoid Development Similar to Schizophrenia-Schizophrenia Increases Developmental Vulnerability to TNFα.
Benson C, Powell H, Liput M, Dinham S, Freedman D, Ignatowski T
Front Cell Neurosci. 2020; 14:233.
PMID: 33005129
PMC: 7484483.
DOI: 10.3389/fncel.2020.00233.
FHF1 is a bona fide fibroblast growth factor that activates cellular signaling in FGFR-dependent manner.
Sochacka M, Opalinski L, Szymczyk J, Zimoch M, Czyrek A, Krowarsch D
Cell Commun Signal. 2020; 18(1):69.
PMID: 32357892
PMC: 7193404.
DOI: 10.1186/s12964-020-00573-2.
A Genome Model to Explain Major Features of Neurodevelopmental Disorders in Newborns.
Friedenson B
Biomed Inform Insights. 2019; 11:1178222619863369.
PMID: 31391780
PMC: 6669855.
DOI: 10.1177/1178222619863369.
Targeting Cellular Trafficking of Fibroblast Growth Factor Receptors as a Strategy for Selective Cancer Treatment.
Porebska N, Latko M, Kucinska M, Zakrzewska M, Otlewski J, Opalinski L
J Clin Med. 2018; 8(1).
PMID: 30577533
PMC: 6352210.
DOI: 10.3390/jcm8010007.
Cerebral organoids reveal early cortical maldevelopment in schizophrenia-computational anatomy and genomics, role of FGFR1.
Stachowiak E, Benson C, Narla S, Dimitri A, Chuye L, Dhiman S
Transl Psychiatry. 2018; 7(11):6.
PMID: 30446636
PMC: 5802550.
DOI: 10.1038/s41398-017-0054-x.
Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS).
Narla S, Lee Y, Benson C, Sarder P, Brennand K, Stachowiak E
Schizophr Res. 2017; 185:17-32.
PMID: 28094170
PMC: 5507209.
DOI: 10.1016/j.schres.2016.12.012.
Covalent Targeting of Fibroblast Growth Factor Receptor Inhibits Metastatic Breast Cancer.
Brown W, Tan L, Smith A, Gray N, Wendt M
Mol Cancer Ther. 2016; 15(9):2096-106.
PMID: 27371729
PMC: 5010989.
DOI: 10.1158/1535-7163.MCT-16-0136.